Immunopathogenesis of dengue virus infection

被引:233
作者
Lei, HY [1 ]
Yeh, TM
Liu, HS
Lin, YS
Chen, SH
Liu, CC
机构
[1] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 701, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Dept Med Technol, Tainan 701, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 701, Taiwan
关键词
dengue virus;
D O I
10.1007/BF02255946
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Dengue virus infection causes dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS), whose pathogeneses are not clearly understood. Current hypotheses of antibody-dependent enhancement, virus virulence, and IFN-gamma /TNF alpha -mediated immunopathogenesis are insufficient to explain clinical manifestations of DHF/DSS such as thrombocytopenia and hemoconcentration. Dengue virus infection induces transient immune aberrant activation of CD4/CD8 ratio inversion and cytokine overproduction, and infection of endothelial cells and hepatocytes causes apoptosis and dysfunction of these cells. The coagulation and fibrinolysis systems are also activated after dengue virus infection. We propose a new hypothesis for the immunopathogenesis for dengue virus infection. The aberrant immune responses not only impair the immune response to clear the virus, but also result in overproduction of cytokines that affect monocytes, endothelial cells, and hepatocytes. Platelets are destroyed by crossreactive anti-platelet autoantibodies. Dengue-virus-induced vasculopathy and coagulopathy must be involved in the pathogenesis of hemorrhage, and the unbalance between coagulation and fibrinolysis activation increases the likelihood of severe hemorrhage in DHF/DSS. Hemostasis is maintained unless the dysregulation of coagulation and fibrinolysis persists. The overproduced IL-6 might play a crucial role in the enhanced production of anti-platelet or anti-endothelial cell autoantibodies, elevated levels of tPA, as well as a deficiency in coagulation. Capillary leakage is triggered by the dengue virus itself or by antibodies to its antigens. This immunopathogenesis of DHF/DSS can account for specific characteristics of clinical, pathologic, and epidemiological observations in dengue virus infection. Copyright (C) 2001 National Science Council, ROC and S. Karger AG, Basel.
引用
收藏
页码:377 / 388
页数:12
相关论文
共 90 条
  • [81] Invited commentary: Dengue lessons from Cuba
    Vaughn, DW
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (09) : 800 - 803
  • [82] ANTIBODY-ENHANCED BINDING OF DENGUE-2 VIRUS TO HUMAN PLATELETS
    WANG, SG
    HE, RT
    PATARAPOTIKUL, J
    INNIS, BL
    ANDERSON, R
    [J]. VIROLOGY, 1995, 213 (01) : 254 - 257
  • [83] Strain differences in natural killer cell-mediated immunity among mice: A possible mechanism for the low natural killer cell activity of A/J mice
    Whyte, AL
    Miller, SC
    [J]. IMMUNOBIOLOGY, 1998, 199 (01) : 23 - 38
  • [84] World Health Organization, 1986, DENG HAEM FEV DIAGN
  • [85] World Health Organization (WHO), 1997, DENG HAEM FEV DIAGN
  • [86] Human skin Langerhans cells are targets of dengue virus infection
    Wu, SJL
    Grouard-Vogel, G
    Sun, W
    Mascola, JR
    Brachtel, E
    Putvatana, R
    Louder, MK
    Filgueira, L
    Marovich, MA
    Wong, HK
    Blauvelt, A
    Murphy, GS
    Robb, ML
    Innes, BL
    Birx, DL
    Hayes, CG
    Frankel, SS
    [J]. NATURE MEDICINE, 2000, 6 (07) : 816 - 820
  • [87] DENGUE HEMORRHAGIC-FEVER AND DENGUE SHOCK SYNDROME - ARE THEY TUMOR NECROSIS FACTOR-MEDIATED DISORDERS
    YADAV, M
    KAMATH, KR
    IYNGKARAN, N
    SINNIAH, M
    [J]. FEMS MICROBIOLOGY IMMUNOLOGY, 1991, 89 (01): : 45 - 49
  • [88] YOTO Y, 1993, EUR J HAEMATOL, V50, P255
  • [89] IMMUNIZATION OF MICE WITH DENGUE STRUCTURAL PROTEINS AND NONSTRUCTURAL PROTEIN NS1 EXPRESSED BY BACULOVIRUS RECOMBINANT INDUCES RESISTANCE TO DENGUE VIRUS ENCEPHALITIS
    ZHANG, YM
    HAYES, EP
    MCCARTY, TC
    DUBOIS, DR
    SUMMERS, PL
    ECKELS, KH
    CHANOCK, RM
    LAI, CJ
    [J]. JOURNAL OF VIROLOGY, 1988, 62 (08) : 3027 - 3031
  • [90] 1999, SURVEILLANCE REPORT, V15, P14